Cargando…
Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study
Valproate is an anticonvulsant, which is also widely used for treating psychiatric disorders. Some clinical trials have demonstrated benefits of valproate augmentation therapy in schizophrenia. Previous meta-analysis showed inconsistent findings because of limited literature at that time. The aim of...
Autores principales: | Tseng, Ping-Tao, Chen, Yen-Wen, Chung, Weilun, Tu, Kun-Yu, Wang, Hung-Yu, Wu, Ching-Kuan, Lin, Pao-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291556/ https://www.ncbi.nlm.nih.gov/pubmed/26825886 http://dx.doi.org/10.1097/MD.0000000000002475 |
Ejemplares similares
-
Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder: A preliminary meta-analysis under MOOSE guidelines
por: Wu, Ching-Kuan, et al.
Publicado: (2016) -
Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA
por: Tu, Kun-Yu, et al.
Publicado: (2016) -
Significantly Higher Prevalence Rate of Asthma and Bipolar Disorder Co-Morbidity: A Meta-Analysis and Review Under PRISMA Guidelines
por: Wu, Ming-Kung, et al.
Publicado: (2016) -
Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMA
por: Tseng, Ping-Tao, et al.
Publicado: (2015) -
Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines
por: Li, Dian-Jeng, et al.
Publicado: (2016)